Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Asan Medical Center
Seoul, Songpa-gu, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
- Chang-Gung Memorial Hospital - Kaohsiung Branch
Kaohsiung City, Taiwan
- China Medical University Hospital
Taichung, Taiwan
- National Cheng Kung University Hospitals
Tainan, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Chang-Gung Memorial Hospital - Linkou Branch
Taoyuan City, Taiwan
- Mayo Clinic
Scottsdale, Arizona, United States
- University of Colorado- Denver
Aurora, Colorado, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States
- Texas Oncology-Tyler
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 6 Nov 2020
- Completion
- 5 Aug 2021
- Last update posted
- 22 Oct 2021
- Registered enrollment
- 127
- Registry id
- NCT02128282
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.